Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Gritstone Oncology Inc (NASDAQ:GRTS) Begins Phase 1 Clinical Study Of COVID-19…
Timber Pharmaceuticals Inc (NYSE:TMBR) Receives ODD For TMB-003 From The US…
CASI Pharmaceuticals Inc (NASDAQ:CASI) Reports A Growth Of 265% YoY In…
NovaBay Pharmaceuticals (NYSE:NBY) Reports Revenues Of $1.9 Million In Q4 2020:…
Atossa Therapeutics Inc (NASDAQ:ATOS) Reports Positive Interim Results From Phase 2…
Finance
GeoVax Labs (GOVX) surges on positive sentiment
Compass Pathways (CMPS) could lead psychedelic sector
Moderna Inc (NASDAQ:MRNA) Signs Deal With Baxter International Inc (NYSE:BAX) For…
Bitcoin Stocks for the Win (SQ, RIOT, ISWH, HVBTF)
The Contrarian Opportunity in Sports Stocks (CHDN, DKNG, BTDG, DKS)
Tech News
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
NASDAQ:SAVA
Tag: NASDAQ:SAVA
Cassava Sciences Inc. (NASDAQ:SAVA) Released Addition Phase 2b Clinical Study Results...
Ward Sport
-
November 10, 2020
0
CTAD 2020 Picks Cassava Sciences Inc.’s (NASDAQ:SAVA) Phase 2b Sumifilam Study...
Matt Wade
-
October 14, 2020
0
Cassava Sciences Inc. (NASDAQ:SAVA) Demonstrates Directional Improvement In Alzheimer’s Patients Treated...
Matt Wade
-
September 17, 2020
0
The USAN Announces a Commercial Brand Name for PTI-125; Lead Drug...
Kate Hudson
-
September 1, 2020
0
Cassava Sciences Inc (NASDAQ:SAVA) Expects To Release Clinical Results Of Phase...
Kate Hudson
-
August 26, 2020
0
.td-post-views{ display: none !important; }
